Long lasting growth hormone releasing factor derivatives
US7268113B2 · kind B2 · utility
23Cited by
29References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2002 |
| Grant date | Sep 11, 2007 |
| Priority date | — |
| Expiry date | Aug 11, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to growth hormone releasing factor (GRF) derivatives. In particular, this invention relates to GRF peptide derivatives having an extended in vivo half-life, for promoting the endogenous production or release of growth hormone in humans and animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.